|
1
|
Al Suleimani YM and Walker MJ: Allergic
rhinitis and its pharmacology. Pharmacol Ther. 114:233–260. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Cheng L, Chen J, Fu Q, He S, Li H, Liu Z,
Tan G, Tao Z, Wang D, Wen W, et al: Chinese society of allergy
guidelines for diagnosis and treatment of allergic rhinitis.
Allergy Asthma Immunol Res. 10:300–353. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kakli HA and Riley TD: Allergic Rhinitis.
Prim Care. 43:465–475. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zhang L, Han D, Huang D, Wu Y, Dong Z, Xu
G, Kong W and Bachert C: Prevalence of self-reported allergic
rhinitis in eleven major cities in China. Int Arch Allergy Immunol.
149:47–57. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bao Y, Chen J, Cheng L, Guo Y, Hong S,
Kong W, Lai H, Li H, Li H, Li J, et al: Chinese Guideline on
allergen immunotherapy for allergic rhinitis. J Thorac Dis.
9:4607–4650. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Du K, Qing H, Zheng M, Wang X and Zhang L:
Intranasal antihistamine is superior to oral H1
antihistamine as an add-on therapy to intranasal corticosteroid for
treating allergic rhinitis. Ann Allergy Asthma Immunol.
125:589–596.e3. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
McColl A, Michlewska S, Dransfield I,
Dransfield I and Rossi AG: Effects of glucocorticoids on apoptosis
and clearance of apoptotic cells. ScientificWorldJournal.
7:1165–1181. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Mims JW: Epidemiology of allergic
rhinitis. Int Forum Allergy Rhinol. 4 (Suppl 2):S18–S20. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ahmadiafshar A and Ahmadiafshar S:
Efficacy and safety of inhaled and intranasal corticosteroids.
Antiinflamm Antiallergy Agents Med Chem. 13:83–87. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wheatley LM and Togias A: Clinical
practice. Allergic rhinitis. N Engl J Med. 372:456–463. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hossenbaccus L, Linton S, Garvey S and
Ellis AK: Towards definitive management of allergic rhinitis: Best
use of new and established therapies. Allergy Asthma Clin Immunol.
16:392020. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Jiang H, Li J, Wang L, Wang S, Nie X, Chen
Y, Fu Q, Jiang M, Fu C and He Y: Total glucosides of paeony: A
review of its phytochemistry, role in autoimmune diseases, and
mechanisms of action. J Ethnopharmacol. 258:1129132020. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Huang XT, Wang B, Zhang WH, Peng MQ and
Lin D: Total glucosides of paeony suppresses experimental
autoimmune uveitis in association with inhibition of Th1 and Th2
cell function in mice. Int J Immunopathol Pharmacol.
32:3946320177515472018.PubMed/NCBI
|
|
14
|
Lin J, Xiao L, Ouyang G, Shen Y, Huo R,
Zhou Z, Sun Y, Zhu X, Zhang J, Shen B and Li N: Total glucosides of
paeony inhibits Th1/Th17 cells via decreasing dendritic cells
activation in rheumatoid arthritis. Cell Immunol. 280:156–163.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhou L, Cao T, Wang Y, Yao H, Du G, Tian Z
and Tang G: Clinical observation on the treatment of oral lichen
planus with total glucosides of paeony capsule combined with
corticosteroids. Int Immunopharmacol. 36:106–110. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhou Y, Jin L, Kong F, Zhang H, Fang X,
Chen Z, Wang G and Li X and Li X: Clinical and immunological
consequences of total glucosides of paeony treatment in Sjögren's
syndrome: A randomized controlled pilot trial. Int Immunopharmacol.
39:314–319. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Berker M, Frank LJ, Geßner AL, Grassl N,
Holtermann AV, Höppner S, Kraef C, Leclaire MD, Maier P, Messerer
DA, et al: Allergies-A T cells perspective in the era beyond the
TH1/TH2 paradigm. Clin Immunol. 174:73–83.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Eifan AO and Durham SR: Pathogenesis of
rhinitis. Clin Exp Allergy. 46:1139–1151. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sporn MB and Roberts AB: Transforming
growth factor-beta: Recent progress and new challenges. J Cell
Biol. 119:1017–1021. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lawrence DA: Transforming growth
factor-beta: A general review. Eur Cytokine Netw. 7:363–374.
1996.PubMed/NCBI
|
|
21
|
Salib RJ, Kumar S, Wilson SJ and Howarth
PH: Nasal mucosal immunoexpression of the mast cell
chemoattractants TGF-beta, eotaxin, and stem cell factor and their
receptors in allergic rhinitis. J Allergy Clin Immunol.
114:799–806. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Xie L, Yu S, Yang K, Li C and Liang Y:
Hydrogen sulfide inhibits autophagic neuronal cell death by
reducing oxidative stress in spinal cord ischemia reperfusion
injury. Oxid Med Cell Longev. 2017:86402842017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chaudhury D, Walsh JJ, Friedman AK, Juarez
B, Ku SM, Koo JW, Ferguson D, Tsai HC, Pomeranz L, Christoffel DJ,
et al: Rapid regulation of depression-related behaviours by control
of midbrain dopamine neurons. Nature. 493:532–536. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Naclerio RM, Meier HL, Kagey-Sobotka A,
Adkinson NF Jr, Meyers DA, Norman PS and Lichtenstein LM: Mediator
release after nasal airway challenge with allergen. Am Rev Respir
Dis. 128:597–602. 1983.PubMed/NCBI
|
|
25
|
Zhang Y, Lan F and Zhang L: Advances and
highlights in allergic rhinitis. Allergy. 76:3383–3389. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Geng B, Dilley M and Anterasian C:
Biologic therapies for allergic rhinitis and nasal polyposis. Curr
Allergy Asthma Rep. 21:362021. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Jiao C, Li L, Zhang P, Zhang L, Li K, Fang
R, Yuan L, Shi K, Pan L, Guo Q, et al: REGү ablation impedes
dedifferentiation of anaplastic thyroid carcinoma and accentuates
radio-therapeutic response by regulating the Smad7-TGF-β pathway.
Cell Death Differ. 27:497–508. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhu Z, Xu Y, Zhao J, Liu Q, Feng W, Fan J
and Wang P: MiR-367 promotes epithelial-to-mesenchymal transition
and invasion of pancreatic ductal adenocarcinoma cells by targeting
the Smad7-TGF-β signalling pathway. Br J Cancer. 112:1367–1375.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhang L, Yu J, Wang C and Wei W: The
effects of total glucosides of paeony (TGP) and paeoniflorin (Pae)
on inflammatory-immune responses in rheumatoid arthritis (RA).
Funct Plant Biol. 46:107–117. 2019. View
Article : Google Scholar : PubMed/NCBI
|
|
30
|
Liu G, Wang Z, Li X, Liu R, Li B, Huang L,
Chen Y, Zhang C, Zhang H, Li Y, et al: Total glucosides of paeony
(TGP) alleviates constipation and intestinal inflammation in mice
induced by SjC6gren's syndrome. J Ethnopharmacol. 260:1130562020.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Chen H, Wen Y, Pan T and Xu S: Total
glucosides of paeony improve complete freund's adjuvant-induced
rheumatoid arthritis in rats by inhibiting toll-like receptor
2-mediated tumor necrosis factor receptor-associated factor
6/nuclear factor-kappa B pathway activation. J Tradit Chin Med.
39:566–574. 2019.PubMed/NCBI
|
|
32
|
Shen M, Men R, Fan X, Wang T, Huang C,
Wang H, Ye T, Luo X and Yang L: Total glucosides of paeony
decreases apoptosis of hepatocytes and inhibits maturation of
dendritic cells in autoimmune hepatitis. Biomed Pharmacother.
124:1099112020. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Sies H: Oxidative stress: A concept in
redox biology and medicine. Redox Biol. 4:180–183. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Hybertson BM, Gao B, Bose SK and McCord
JM: Oxidative stress in health and disease: The therapeutic
potential of Nrf2 activation. Mol Aspects Med. 32:234–246. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Burton GJ and Jauniaux E: Oxidative
stress. Best Pract Res Clin Obstet Gynaecol. 25:287–299. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Sim CS, Lee JH, Kim SH, Han MW, Kim Y, Oh
I, Yun SC and Lee JC: Oxidative stress in schoolchildren with
allergic rhinitis: Propensity score matching case-control study.
Ann Allergy Asthma Immunol. 115:391–395. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Celik M, Tuncer A, Soyer OU, Sac'kesen C,
Tanju Besler H and Kalayci O: Oxidative stress in the airways of
children with asthma and allergic rhinitis. Pediatr Allergy
Immunol. 23:556–561. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Wei Choo CY, Yeh KW, Huang JL, Su KW, Tsai
MH, Hua MC, Liao SL, Lai SH, Chen LC and Chiu CY: Oxidative stress
is associated with atopic indices in relation to childhood rhinitis
and asthma. J Microbiol Immunol Infect. 54:466–473. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Xu X, Lai Y and Hua ZC: Apoptosis and
apoptotic body: Disease message and therapeutic target potentials.
Biosci Rep. 39:BSR201809922019. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Du L, Meng Q, Chen Y and Wu P: Subcellular
location prediction of apoptosis proteins using two novel feature
extraction methods based on evolutionary information and LDA. BMC
Bioinformatics. 21:2122020. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Wang ZA and Tan F: The blockade of
PD-1/PD-L1 pathway promotes the apoptosis of CD19+
CD25+ Bregs and suppresses the secretion of IL-10 in
patients with allergic rhinitis. Scand J Immunol. 91:e128362020.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Kim DK, Choi SA, Eun KM, Kim SK, Kim DW
and Phi JH: Tumour necrosis factor alpha and interleukin-5 inhibit
olfactory regeneration via apoptosis of olfactory sphere cells in
mice models of allergic rhinitis. Clin Exp Allergy. 49:1139–1149.
2019.PubMed/NCBI
|
|
43
|
Ventura MT, Bruno LM, Iacobelli A and
Tursi A: Eosinophils in allergic diseases: Immunopharmacological
regulation. Immunopharmacol Immunotoxicol. 19:405–423. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Liu J, Jiang Y, Han M, Jiang L, Liang D,
Li S, Xu Z, Wang L and Li N: MicroRNA-345-5p acts as an
anti-inflammatory regulator in experimental allergic rhinitis via
the TLR4/NF-κB pathway. Int Immunopharmacol. 86:1065222020.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Wang L, Lv Q, Song X, Jiang K and Zhang J:
ADRB2 suppresses IL-13-induced allergic rhinitis inflammatory
cytokine regulated by miR-15a-5p. Hum Cell. 32:306–315. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Lei H, Sun Y and Quan S: IL-37 relieves
allergic inflammation by inhibiting the CCL11 signaling pathway in
a mouse model of allergic rhinitis. Exp Ther Med. 20:3114–3121.
2020.PubMed/NCBI
|
|
47
|
Xu W, Zhao Y, Qin Y, Ge B, Gong W, Wu Y,
Li X, Zhao Y, Xu P and Xue M: Enhancement of exposure and reduction
of elimination for paeoniflorin or albiflorin via co-administration
with total peony glucosides and hypoxic pharmacokinetics
comparison. Molecules. 21:8742016. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Tabata K, Matsumoto K, Murakami Y and
Watanabe H: Ameliorative effects of paeoniflorin, a major
constituent of peony root, on adenosine A1 receptor-mediated
impairment of passive avoidance performance and long-term
potentiation in the hippocampus. Biol Pharm Bull. 24:496–500. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Chen DM, Xiao L, Cai X, Zeng R and Zhu XZ:
Involvement of multitargets in paeoniflorin-induced
preconditioning. J Pharmacol Exp Ther. 319:165–180. 2006.
View Article : Google Scholar : PubMed/NCBI
|
